Table of contents

Clinical and epidemiological research

• Extended report: Development of quality indicators for monitoring of the disease course in rheumatoid arthritis (15 May, 2009)

  L T C van Hulst, J Fransen, A A den Broeder, R Grol, P L C M van Riel, M E J L Hulscher
• Extended report: ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis (5 December, 2008)

  D van der Heijde, E Lie, T K Kvien, J Sieper, F Van den Bosch, J Listing, J Braun, R Landewé, for the Assessment of SpondyloArthritis international Society (ASAS)
• Extended report: Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment (3 December, 2008)

  T A Simon, A L Smitten, J Franklin, J Askling, D Lacaille, F Wolfe, M C Hochberg, K Qi, S Suissa
• Extended report: Modification and validation of the Birmingham Vasculitis Activity Score (version 3) (3 December, 2008)

  C Mukhtyar, R Lee, D Brown, D Carruthers, B Dasgupta, S Dubey, O Flossmann, C Hall, J Hollywood, D Jayne, R Jones, P Lanyon, A Muir, D Scott, L Young, R A Luqmani
• Extended report: Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis (9 December, 2008)

  J N Hoes, J W G Jacobs, S M M Verstappen, J W J Bijlsma, G J M G Van der Heijden
• Extended report: Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study (9 December, 2008)

  D Vosse, R Landewé, D van der Heijde, S van der Linden, T-P van Staa, P Geusens
• Extended report: Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials (3 December, 2008)

  C Gaujoux-Viala, M Dougados, L Gossec
• Extended report: Reliability of high-resolution ultrasonography in the assessment of Achilles tendon enthesopathy in seronegative spondyloarthropathies (8 April, 2009)

  E Filippucci, S Zehra Aydin, O Karadag, F Salaffi, M Gutierrez, H Direskeneli, W Grassi
• Extended report: Comparative effectiveness of tumour necrosis factor α inhibitors in combination with either methotrexate or leflunomide (6 January, 2009) Free

  A Strangfeld, F Hierse, J Kekow, U von Hinueber, H-P Tony, R Dockhorn, J Listing, A Zink
• Extended report: Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases (15 January, 2009)

  G R Burmester, P Mease, B A C Dijkmans, K Gordon, D Lovell, R Panaccione, J Perez, A L Pangan
• Extended report: Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors (5 January, 2009)

  R Westhovens, M Robles, A C Ximenes, S Nayiager, J Wollenhaupt, P Durez, J Gomez-Reino, W Grassi, B Haraoui, W Shergy, S-H Park, H Genant, C Peterfy, J-C Becker, A Covucci, R Helfrick, J Bathon
• Extended report: Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients (3 December, 2008)

  A-L Hachulla, D Launay, V Gaxotte, P de Groote, N Lamblin, P Devos, P-Y Hatron, J-P Beregi, E Hachulla
• Extended report: N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment? (3 December, 2008)

  Y Allanore, K Wahbi, D Borderie, S Weber, A Kahan, C Meune
• Concise report: Natural course of knee osteoarthritis in middle-aged subjects with knee pain: 12-year follow-up using clinical and radiographic criteria (3 December, 2008)

  C A Thorstensson, M L E Andersson, H Jönsson, T Saxne, I F Petersson
• Concise report: Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients (20 January, 2009)

  M C Genovese, F C Breedveld, P Emery, S Cohen, E Keystone, E L Matteson, Y Baptiste, A Chai, L Burke, W Reiss, M Sweetser, T M Shaw
• Concise report: Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study (21 April, 2009)

  G Haugeberg, P G Conaghan, M Quinn, P Emery